CDKN2A and astrocytic tumor: The findings of our retrospective small cohort study suggest that in astrocytic tumors, PTEN mut/loss, EGFR mut/amp, and CDKN2A/B HD are strong MET accumulation factors, and NF1 mut/loss is a strong FDG accumulation factor.